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The fungal pathogen Candida albicans is one of the leading causative agents of death in immunocompromised individuals. It
harbors an arsenal of cell wall anchored factors that are implicated in virulence such as filamentation inducing factors, adhesins,
lipases, proteases, and superoxide dismutases. Dse1 is a cell wall protein involved in cell wall metabolism. The purpose of this
study is to characterize the role Dse1 plays in virulence. Dse1 appears to be an essential gene as no homozygous null mutant
was possible. The heterozygote mutant exhibited increased susceptibility to calcofluor white, a cell wall disrupting agent, with a
subsequent reduction in cell wall chitin content, decreased oxidative stress tolerance, a 30% reduction in biofilm formation, and
a delay in adhesion that was mirrored by a reduction in virulence in a mouse model of infection. Dse1 thus appears to be an
important protein involved in cell wall integrity and rigidity.
1. Introduction
Candida albicans is the most common fungal pathogen in
humans. This fungus exists as a commensal organism in
healthy individuals by colonizing several niches of the human
body [1]. These niches include skin and mucosal surfaces,
oral cavity, vagina, and gastrointestinal tract. An altered
balance between the host immunity and this opportunistic
fungus, as in the case of immunocompromised patients, is
one of the leading causes of candidiasis in humans. After
entering the bloodstream, the yeast cells can infect all internal
organs and may cause life-threatening septicemia [2]. In the
USA, candidiasis is considered the third most common
blood-borne infection and the fourth major cause of noso-
comial infections. Candidiasis can develop as superficial
candidiasis (skin and mucosa) which occurs in healthy
individuals, or invasive candidiasis which is seen in cancer
patients, AIDS patients, and immunocompromised individ-
uals following transplantation [1]. The latter conditions have
been shown to be associated with a high rate of mortality
which can range between 35% and 60%.
A remarkable characteristic of C. albicans is its ability to
grow in two diﬀerent forms: ellipsoidal buds (blastospores)
or hyphae [3]. This asexual diploid fungus can form blas-
tospores which are free floating cells that grow independently
from each other or hyphae which are elongated cells attached
to each other. The transition between the two forms can be
stimulated by environmental factors such as body tempera-
ture (37◦C), neutral to basic pH, or by some more critical
filamentation inducing factors such as blood serum, hypoxia,
physiological CO2 concentration, carbon and nitrogen star-
vation, and macrophage contact [3, 4]. This capability to
switch between these two distinct morphologies is relevant
to the pathogenicity of this organism since the filamentous
form is necessary for invasive growth and the yeast form for
clonal expansion.
Although candidiasis may arise from an immunologic
dysfunction in the host organism, much credit should be
given to the opportunistic pathogen itself, its ability to adapt
to various niches, and its capability to express many crucial
genes that are involved in infection. Such factors include
adhesins [5, 6], lipases and phospholipases [7, 8], secreted
aspartyl proteases [9], iron acquisition [10], and oxidative
stress response [11]. Most of the above-mentioned factors
are cell wall proteins attached to the the β-1,3 or 1,6 glu-
cans, and face the exterior to interact with the environment.
2 Interdisciplinary Perspectives on Infectious Diseases
In addition to glucans the cell wall contains a stress tolerant
innermost layer of chitin [12, 13]. As suchC. albicans cell wall
proteins have been the subject of intense characterization and
are considered prime targets for novel antifungal drugs.
The purpose of the current study is to characterize Dse1,
a 724 amino acid uncharacterized predicted cell wall protein
whose transcription is decreased in a C. albicans mutant
strain lacking the transcription factor Ace2. Ace2p is a master
regulator of the cell wall metabolism in C. albicans and is
involved in the regulation of transcription during G1 phase
of mitotic cycle [14]. Characterization will be performed
by generating a Dse1 mutant strain and comparing the
phenotype of the null to the parental as far as filamenta-
tion, adhesion to human epithelial cells, biofilm formation,
cell wall chitin content, virulence in a mouse model of
disseminated candidiasis resistance to oxidative stress, and
susceptibility to cell surface disrupting agents.
2. Materials and Methods
2.1. Strains, Cell Lines, and General Growth Conditions.
The RM1000 C. albicans strain (ura3Δ::λimm434/ura3Δ::
λimm434his1::hisG/his1::hisG, [15], which is auxotrophic for
uridine and histidine, was used in this study. Cells were
grown without selection on potato dextrose agar (PDA)
medium (HiMedia, India). When selective growth was
required, the yeast nitrogen base (YNB) synthetic medium
was utilized (Fluka, Switzerland). Media was supplemented
with 75 μM uridine and histidine for all assays carried
out to account for possible diﬀerences in levels of uridine
expression. Images were generated utilizing an Olympus
E330-ADU-1.2x stereomicroscope for colony morphology
and an Olympus CX41 for cell imaging coupled with a Sony
DSC-S40 digital camera. A Sony Cybershot Camera was used
for colony spotting pictures.
The human colon adenocarcinoma cell line HT-29 ATCC
number HTB-38 was utilized in this study. Cells were grown
on RPMI 1640 medium supplemented with 25mM Hepes
and L-glutamine with 10% FBS. 100 μg/mL of streptomycin
and 100U/mL of penicillin were added, and cells were grown
in a 5% CO2 incubator.
2.2. Dse1 KnockoutGeneration. DNAcassettes containing the
functional URA3 or HIS1 markers flanked by 100 bp Dse1
sequences 5′ and 3′ were generated as previously described
[16, 17] of homology. Homologous recombination and inte-
gration created a DSE1/URA3::dse1 and a DSE1/HIS1::dse1
heterozygous strain.
2.3. Cassette Transformation. C. albicans strain RM1000 was
transformed with the previously constructed DSE1-URA3
and DSE1-HIS1 cassettes by using a modified protocol of
the Alkali Yeast Cation Transformation Kit (Q-Biogene, Ger-
many) [18]. The RM 1000 parental strain was transformed
with plasmid pABSK2 to restore uridine prototrophy as
described previously [16, 17]. Successful transformants were
selected on selective YNB medium supplemented with the
appropriate amino acids.
2.4. Filamentation Assay. Strains were grown on PDA for 14
days at 30◦C and 37◦C and then checked for filamentous and
invasive growth on the agar medium. Furthermore, strains
were grown in potato dextrose broth PDB and 100% liquid
fetal bovine serum FBS (HiMedia) for 12 h at 30◦C and 37◦C
and then observed under the microscope.
2.5. Antifungal Susceptibility Test. For caspofungin suscepti-
bility determination, the E-test (AB Biodisk, Solna, Sweden)
performed on RPMI agar supplemented with L-glutamine
and 165mMMOPS (BioWhittaker, Belgium) was performed
according to the manufacturer’s instructions, and the MIC
was read after 48 h of incubation at 35◦C. The C. albicans
ATCC 90028 CLSI quality control reference strain was used
in this study. The MICs of the control strains fell within the
acceptable limits.
2.6. Susceptibility to Cell Wall Disrupting Agents. The wild
type and DSE1/dse1 mutant strains were grown in rich PDB
media until exponential phase (OD600 = 0.6–0.8). Serial
dilutions were performed (105 to 102 cells/mL), and a volume
of 5 μL was spotted on PDA plates containing either one of
the following cell surface disrupting agents: sodium dodecyl
sulfate at a concentration ranging from 0.02% to 0.05%,
calcofluor white at a concentration ranging from 25 to
100 μg/mL, and Congo red at a concentration ranging from
10 to 50 μg/mL. Plates were incubated at 30◦C andmonitored
for 4 days. Plates lacking the disrupting agents were used as
controls [16].
2.7. Oxidative Stress Test. Strains were grown in rich potato
dextrose broth media to exponential phase, then serial dilu-
tions (105 to 102 cells/mL) were prepared and treated with
hydrogen peroxide (10, 25 or 50mM) for 1 hour followed by
spotting 5 μL onto PDA plates. Untreated cultures were also
spotted as controls. Growth was monitored for 3 days [19].
2.8. Adhesion to Epithelial Cells. Adhesion to epithelial cells
was assessed using the HT-29 human cell line and as pre-
viously described [20]. Briefly, strains were grown to expo-
nential phase and subsequently diluted to 100 cells/mL that
were added to six-well microtiter plates containing epithelial
cells and incubated for 45 and 90 minutes at 37◦C. After
incubation, nonadherent cells were removed by washing the
wells twice with PBS; the wells were then overlaid with
molten PDA agar. After 24 hrs, adhesion to epithelial cells
was evaluated by comparing the number of colonies present
on themicrotiter plates with colonies present on control PDA
plates. Adhesion was expressed as a percentage of the original
inoculum.
2.9. Biofilm Assay. The assay was performed as previously
described [21] with slight modification. Briefly, 500 μL of
a 107 cells/mL culture was added onto the wells of a poly-
styrene microtiter plate pretreated with 0.05% fetal bovine
serum for 24 h at 4◦C. Plates were incubated in a shaker at
37◦C and 75 rpm for 3 hrs after which nonadherent cells were
washed away with PBS, 1mL YNB was added to each well,
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and plates were reincubated for 48 h at 37◦C. Plates were
rinsed again with PBS, and 500 μL of 99% methanol was
added to each well to fix the newly formed biofilms. After 15
minutes, methanol was removed and plates were allowed to
air dry. 500 μL of a 0.2% crystal violet solution was added to
each well, and the plate was incubated for 20minutes. Finally,
unbound crystal violet was washed away with distilled water,
and bound crystal violet was released with 750 μL of a 33%
acetic acid solution. Absorbance of the released crystal violet
solution was read at 590 nm. A negative control with no cells
was also performed.
2.10. Disseminated Candidiasis Assay. Eighteen 20–30 grams
BALB/c mice were injected through the lateral tail vein with
5 × 106 C. albicans cells. Mice were monitored for survival
over a period of three weeks. Food and water were given ad
libitum [4].
2.11. Chitin Quantification. Cell wall chitin content was
measured according to a modified protocol described previ-
ously [13, 22]. Briefly, 6N HCl was used to hydrolyze 50mg
wet weight purified cell walls at 100◦C overnight. After cen-
trifugation, the pellet was reconstituted in 1mL of distilled
water. A 0.1mL aliquot of this sample was added to 0.1mL of
solution A (1.5N Na2CO3 in 4% acetylacetone). The mixture
was incubated at 100◦C for 20 minutes, and after cooling to
room temperature, 0.7mL of 96% ethanol was added to the
mixture followed by addition of a 0.1mL of solution B (1.6 g
of p-dimethyl-aminobenzaldehyde in 30mL of concentrated
HCl and 30mL of 96% ethanol). The mixture was incubated
for 1 hour at room temperature, and absorbance of the
samples was measured spectrophotometrically at 520 nm.
The results were plotted against a standard curve generated
by the use of known glucosamine standards taken through
the same procedure as our samples. Chitin amount was
expressed as a percentage of the wild-type strain.
2.12. Homology Assessment. The C. albicans database (http://
www.candidagenome.org/) was used to retrieve the sequence
of the Dse1 gene. Performing a BLAST search of the Dse1
ORF onto the Saccharomyces cerevisiae, database (http://www
.yeastgenome.org/) revealed the closest S. cerevisiae ortho-
logue
2.13. Statistical Analysis. All assays were done in triplicates.
The multiple comparison LSD (least square diﬀerences) test
was used to analyze the results of the biofilm assay. For the
virulence assay, survival analysis was based on the Kaplan
Meier method and the log Rank test. The student t-test
was used for the adhesion assay, and for chitin content
analysis of variance (ANOVA) was carried out with multiple
comparison technique to control for alpha inflation. P value
less than 5% was considered significant.
3. Results
3.1. Deletion Generation. The RM1000 parental strain was
transformed with the 1513 bp URA3 cassette or a 1420 bp
Table 1: Caspofungin susceptibility. The MIC of caspofungin was
measured by the E-test method. No significant diﬀerence between
the wild-type parental and the mutant was observed.
Strains MIC (μg/mL)
Wild type 0.125
Heterozygote 0.094
HIS1 cassette. One URA3 cassette underwent homologous
recombination at one of the two native Dse1 allele sites
resulting in the formation of a DSE1/dse1::URA3 heterozy-
gote strain. Similarly, one HIS1 cassette was integrated at the
Dse1 locus generating aDSE1/dse1::HIS1 strain. To screen for
successful transformation, the cells were selected by growth
on YNB medium lacking uridine, and/or histidine. For
verification of correct integration a primer that hybridized
outside the Dse1 integration cassette locus and a reverse
primer that hybridized inside the URA3 or HIS1 gene were
used for amplification. To confirm the absence or presence of
any Dse1 alleles, a PCR reaction with Dse1 internal primers
was carried out (data not shown).
3.2. Filamentation Assay. The wild-type parental strain
RM1000 harboring the pABSK2 plasmid and the DSE1/
dse1::URA3 heterozygote mutant strains were grown on PDA
plates for 14 days at 30◦C. The mutants showed a marked
diﬀerence in filamentation and invasiveness compared to the
wild-type strain as the filaments were longer and penetrated
deeper into the agar. The mutant was thus hyperfilamentous
(Figure 1(a)). This diﬀerence was also mirrored in liquid
PDB media after overnight growth at 37◦C (Figure 1(b)). No
diﬀerence on FBS was observed as both strains filamented
equally well (data not shown).
3.3. Antifungal Susceptibility Test. The E-test method was
used to determine the sensitivity of the mutant heterozygote
strain to the antifungal agent caspofungin. After 48 h of incu-
bation, the mutant strain showed no significant discrepancy
compared to the wild type (Table 1).
3.4. Adhesion Assay. Strains were assayed for adhesion to
the human epithelial cell line HT-29 for 45 and 90 minutes.
After 45 minutes, there was a clear and significant delay in
adhesion of the mutant heterozygote strain as compared to
the wild-type strain (P value less than .001). However, after
90-minute incubation, the wild type and mutant exhibited
similar adhesion capabilities. Thus, the mutant exhibits an
adhesion delay phenotype rather than an adhesion defect
(Figure 2).
3.5. Biofilm Assay. Strains were assayed for biofilm formation
capabilities on plastic polystyrene surfaces. The heterozygote
mutant was significantly defective in biofilm formation by
30% as compared to the wild type (P = .002) (Figure 3).
3.6. Mouse Model of Disseminated Candidiasis. Nine mice/
strains were injected via the tail vein with 5× 106 C. albicans
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Figure 1: Colony morphology on solid and liquid media. (a) Colony morphology of both wild-type (1) and heterozygote mutant (2) strains
grown on PDA at 30◦C clearly indicates an increase in filamentation and invasivness of the mutant compared to the wild type. (30x
magnification). (b) Cell morphology in PDB media after 24 h incubation at 37◦C (1000x magnification).
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Figure 2: Adhesion to human epithelial cells. Strains were incu-
bated with cell line HT-29 for 45 and 90 minutes. After washing
away, any nonadherentcells wells were overlaid with molten PDA.
Adhesion to epithelial cells was assessed by counting the number of
colonies present on the microtiters plates after 24 h and comparing
to control plates. Adhesion was expressed as a percentage of
the original inoculums. As can be seen, the mutant exhibited a
significant delay in adhesion after 45min (P < .001).
cells. Mice were monitored for a period of 3 weeks for
survival. Mice injected with the mutant cells survived for a
significantly longer period when compared to mice injected
with the wild-type cells implying a decrease in virulence for
the mutant strain (P = .001). The median survival was
1.75 days for the wild type and 8 days for the heterozygote
(Figure 4).
3.7. Chitin Content. Cell wall chitin was quantified spec-
trophotometrically by the release of N-acetylglucosamine
monomers after acid hydrolysis of purified cell walls. Note
the statistically significant (P = .02) decrease in chitin con-
tent in the mutant compared to the wild type (Figure 5).
3.8. Oxidative Stress Assay. The wild-type strain and the
DSE1/dse1::URA3 heterozygote mutant strains were sub-
jected to various doses of hydrogen peroxide and spotted
on PDA plates. The mutant strain showed a decrease in
resistance to oxidative stress when compared to the wild type
(Figure 6).
3.9. Cell Surface Disturbing Agents. The wild-type and the
mutant strains were grown in the presence of diﬀerent
Interdisciplinary Perspectives on Infectious Diseases 5
0
0.5
1
1.5
2
2.5
3
3.5
Wild type Heterozygote Negative control
O
.D
60
0
n
m
Strains
Figure 3: Biofilm formation on polystyrene surfaces. Strains were
plated on polystyrene microtiter plates and incubated for 24 h
followed by rinsing and methanol addition to allow the fixation
of biofilm-forming cells. Afterward, crystal violet was added to
stain the newly formed biofilm cells. Unbound crystal violet was
washed away and bound crystal violet was released by adding
acetic acid to the wells. OD at 600 nm of the released crystal violet
was read, and it proportionally corresponded to the amount of
biofilm forming cells present in the wells. The negative control
lacked any C. albicans cells but was treated similarly. Note the
significant defect in biofilm formation in the mutant strain (P =
.002).
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Figure 4: Disseminated model of candidiasis. BALB/c mice were
injected in their tail vein with 5 × 106 C. albicans cells, and survival
was monitored daily. Survival analysis was based on the Kaplan
Meier method and the log Rank test. As can be seen, the mutant
strain is significantly defective in virulence when compared to the
wild type (P = .001).
concentrations of various cell surface disrupting agents. A
control plate contained the same dilutions of both strains
but with no disrupting agents added was also performed.
The mutant strain was found to be slightly more suscep-
tible to calcofluor white and SDS when compared to the
wild type with no diﬀerence in susceptibility to Congo red
(Figure 7).
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Figure 5: Chitin content. Cell wall chitin content was measured as
absorbance at OD600 of N-acetylglucosamine monomers released
after HCl hydrolysis of 50mg purified cell walls. Mutant chitin
content was 84% that of the wild type (P = .02).
4. Discussion
In this study, we characterized Dse1, a predicted C. albicans
cell wall protein. The reason behind our choice of this specific
cell wall protein was that even though Dse1 has not yet been
characterized, Ace2, its transcriptional regulator, and the
Saccharomyces cerevisiae Dse1 orthologue have both been. In
Candida, an ace2/ace2 knockout strain exhibits many inter-
esting phenotypes including an increase in filamentation
and agar invasion, a cell separation defect, a reduction in
adherence, a sharp decrease in biofilm formation [14], and
avirulence in a mouse model of infection [23]. The deletion
of the ACE2 gene reduces the expression of two cell wall
genes Dse1 and SCW11 in both yeast and hyphal form. The
deletion has also an eﬀect on the CHT3 gene encoding a
chitinase enzyme which is involved in chitin production in
the cell [14]. In Candida, the Dse1 gene also shows a pattern
of periodic expression with a peak expression at the M/G1
phase [24]. The CaDSE1 orthologue in S. cerevisiae is ScDSE1
which is specifically a daughter cell protein, and it is involved
in pathways controlling cell wall metabolism. Additionally, a
mutant S. cerevisiae strain lacking the Dse1 gene is defective
in cell separation [25, 26]. An alignment of CaDse1p and
ScDse1p revealed a 53% sequence homology between the two
proteins.
Since C. albicans is a diploid organism, characterization
of Dse1 function required knocking out both alleles. An
interesting outcome of our study was our inability to
generate a dse1 homozygous null strain. Twenty-six colonies
from 3 independent transformations of the DSE1/dse1::HIS1
heterozygote with the URA3 cassette were obtained. In all
the twenty-six screened colonies, the presence of a Dse1
internal PCR product indicated a failure in the generation
of a homozygous null strain. On the other hand, 3 out
of 5 colonies of the parental RM1000 strain transformed
with the HIS1 cassette had the cassette integrated at the
correct site and were thus heterozygous. This observation
implied the possibility that the problem may have been in
the URA3 cassette itself rendering it unable to successfully
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Figure 6: Oxidative stress assay. (a) Control plate; (b) 10mM con-
centration of H2O2; (c) 25mM concentration of H2O2. Strains were
grown in PDB, then diluted (105 to 102 cells/mL), and incubated
with diﬀerent doses of hydrogen peroxide for one hour. 5 μL of
the treated culture was spotted on PDA plates. Untreated cultures
were also spotted as controls. Note the increased susceptibility of
the mutant to hydrogen peroxide.
integrate at the correct Dse1 locus and thus preventing the
generation of a Dse1 null strain. To address this problem,
we attempted to recreate the Dse1 heterozygote strain but by
transforming the parental strain with the URA3 cassette first.
Such a heterozygote was successfully generated (5 successful
integrations out of 5 colonies screened). The fact that each
cassette was independently transformed successfully but
the combination could not strongly imply that the Dse1
gene is essential. This conclusion is supported by failure of
generation of a Dse1 null strain from another lab group
utilizing a diﬀerent technique, theUAU1 cassette transforma-
tion (http://www.candidagenome.org/ unpublished data). As
such, the presence of a Dse1 allele in all transformants
with two Dse1 alleles knocked out is a further proof of the
essentiality of the protein. Such a result is interesting and
quite unpredictable since an ace2 null strain does exist and
Ace2 is the only known activator of Dse1, suggesting other
uncharacterized pathways of Dse1 activation.
Since a heterozygote strain with only one copy of a par-
ticular gene usually produces less functional protein than a
wild-type strain with two functional alleles, a haploinsuﬃ-
ciency phenotype is common in C. albicans. This is true of
many cell wall proteins. For instance, a C. albicans mutant
strain, heterozygote for the DDR48 gene, has been shown to
be haploid insuﬃcient as it was defective in filamentation,
hypersensitive to oxidative stress, and reduced levels of drug
resistance [4]. Similarly, an SOD5 heterozygote strain was
shown to be haploinsuﬃcient and was more susceptible
to oxidative stress and less virulent in a mouse model of
infection [27]. In our study, we determined the phenotypic
diﬀerence between the ura3+ heterozygote mutant strain
and the wild-type parental strain, and we found that our
mutant strain exhibited a significant degree of haploinsuf-
ficiency.
It was previously documented that the outcome of cell
wall mutations in C. albicans is a weakened cell wall, and in
most cases of cell wall protein deletions, the resulting cell
tends to be more susceptible to antifungal agents, drugs,
and oxidative stress [4]. Such data agrees with the results
of our study concerning a more weakened cell surface. For
instance, discrepancies were observed between the mutant
and the wild type upon incubation with calcofluor white,
a drug that targets exclusively the C. albicans cell wall, with
the mutant exhibiting an increase in sensitivity. Interestingly,
however, there was no diﬀerence between our mutant and
the wild type concerning sensitivity to Congo red and
caspofungin even though these two drugs also target the
cell wall. A possible explanation of this phenomenon is that
the mechanism of action of calcofluor white is somewhat
diﬀerent from that of Congo red and caspofungin. Calcofluor
white aﬀects chitin assembly within the cell wall, whereas
Congo red and caspofungin alter glucan synthesis and
assembly [28–30]. This hypothesis is further strengthened
by our finding that chitin deposition is also slightly but
statistically significantly decreased in the mutant resulting
in a less rigid cell wall. The mutant was also found to be
more sensitive to SDS and to oxidative stress when compared
to the wild type. SDS is known to disrupt and solubilize
the plasma membrane and is thus not a cell wall-specific
compound [31]. However by weakening the cell wall,
permeability to SDS might have increased rendering the cell
more susceptible. As far as hydrogen peroxide is concerned,
one possible explanation is that by decreasing the amount
of Dse1 on the cell surface, the architecture of the cell
wall proteome might have been changed possibly preventing
correct positioning and anchoring of cell wall localized
superoxide dismutases or other proteins that are directly or
indirectly responsible for countering oxidative stress damage
[32].
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Figure 7: Cell surface disrupting agents. (a) Control plate; (b) 12.5 μg/mL calcofluor white; (c) 0.0225% SDS; (d) 50 μg/mL Congo red.
Strains were grown in PDB, then diluted (105 to 102 cells/mL), and spotted on PDA plates containing diﬀerent concentrations of cell surface
disrupting agents. A slight increase in susceptibility to SDS and calcofluor white was observed.
The above-mentioned rational might also explain the
defect observed in biofilm formation, as changes to the cell
wall proteome brought on by the Dse1 deletion and subse-
quent weakening of the cell wall might have hindered the
ability of the strain to aggregate and form proper biofilm.
Surprisingly, the adhesion data does not go hand in hand
with our biofilm data. A defect in biofilm can be in most
cases explained as due to a defect in adhesion, the first
and necessary step for biofilm formation to proceed [33].
However, the adhesion data showed that the mutant strain
is not defective in adhesion; it rather displays a delay in
adhesion. Whether this delay aﬀects biofilm formation is
debatable. The defect in biofilm formation might be due
to other factors besides adhesion to plastic factors that are
needed in advanced stages of biofilm formation that might
involve protein aggregation or cell-to-cell recognition and
adhesion.
Furthermore, after testing the degree of virulence of our
mutant in a mouse model, it was observed that the mutant
was decreased in virulence when compared to the wild type.
While the wild-type strain was able to kill all mice within
two days after injection, the mutant strain took more than
two weeks to kill the mice. Although the mutant strain
was eventually able to kill all mice, the delay is statistically
significant and implies attenuated virulence. Bearing inmind
that virulence highly correlates with adhesion and vice versa
[34], our results show that the delay in adhesion and defect
in biofilm formation was mirrored by a decrease in virulence.
One possible explanation may be that the delay in adhesion
allows for a crucial amount of time for the immune system
to get rid of the fungus [20].
Our results show similarity with those of an ace2 null.
However, the phenotype exhibited by the ace2/ace2 mutant
is more severe and can be explained by the fact that Ace2
controls not just Dse1 but many proteins implicated in cell
wall metabolism. In addition, the ace2 null exhibited an
increased invasion on solid media and filamentation. Such
a phenotype was also mirrored in our Dse1 null strain as
our strain was overfilamentous on both solid and liquid
media compared to the parental strain with an increase
in invasion of solid agar after a fourteen-day incubation
period that allows for glucose depletion, a positive trigger
of filamentation [17]. No explanation was given for such
a phenotype. Whether the cell upregulates filamentation
genes to compensate for the Dse1 deletion remains to be
determined.
Additionally, a Dse1 orthologue named ScDSE1 is also
found in S. cerevisiae and encodes a protein that has been
shown to participate in pathways regulating cell wall
metabolism. A Dse1 deletion in S. cerevisiae renders the
mutant cells more sensitive to cell wall targeting drugs [25,
26], a phenotype similar to what we observed with our
mutant. However, again, and as is the case with the ace2
knockout strain, the Scdse1 null phenotype was more severe
than the one observed for the mutant in our study. Again it is
important to keep in mind here that both the ace2 and Scdse1
mutant strains were homozygous nulls. We were unable to
generate such a null strain, and as such we are comparing
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a null strain with a heterozygote strain that is still producing
a functional protein. Bearing this in mind, it is not surprising
that our phenotype is more subtle.
5. Conclusion
Dse1 appears to be an essential C. albicans cell wall protein
and as such a potential candidate for novel antifungal drugs.
Knocking out one copy of the gene renders the strain
haploinsuﬃcient. This haploinsuﬃciency manifests itself as
a decrease in resistance to caspofungin, a cell wall disrupting
agent, through weakening the cell wall by diminishing the
amount of chitin deposited, a decrease in resistance to
oxidative stress, delayed adhesion, decreased ability to form
biofilm, and a subsequent reduction in virulence. Future
studies should be carried out to answer some core issues
related to this study. In order to explain the hyperfilamentous
phenotype, microarray analysis of the mutant would be very
useful to assess which filamentation pathways may have been
modified to compensate for the deletion. Moreover, MALDI-
TOFmass spectrometric analysis of the cell surface proteome
would be essential in providing us with some insights as to
what changes have occurred in the cell surface architecture
leading to the observable phenotype. Such experiments
would be valuable in completing our study resulting in
further characterization of Dse1 and the exact role it plays
in C. albicans.
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